v3.26.1
Consolidated Schedule of Investments (Tables)
3 Months Ended
Mar. 31, 2026
Notes Tables  
Summary Investment Holdings [Table Text Block]

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST

BASIS

  

VALUE

 

INTRAOP MEDICAL CORP.

                   

((0.2%))
Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/11/2019

  500,000  $500,000  $13 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/22/2021

  1,000,000   1,000,000   27 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/29/2019

  500,000   500,000   13 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

10/6/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

11/12/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

11/29/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

12/31/2018

  10,961,129   10,961,129   297 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

2/27/2020

  1,000,000   1,000,000   27 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

2/28/2022

  200,000   200,000   5 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

3/25/2020

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

3/30/2022

  150,000   150,000   4 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

3/8/2020

  400,000   400,000   11 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

4/20/2021

  1,000,000   1,000,000   27 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

4/6/2022

  350,000   350,000   9 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY 

INTEREST

RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST

BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

                   
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

6/10/2021

  500,000  $500,000  $14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

6/10/2022

  700,000   700,000   19 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

7/12/2019

  1,300,000   1,300,000   35 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

7/16/2021

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

7/31/2020

  500,000   500,000   14 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

8/28/2020

  750,000   750,000   20 
 

Convertible Note (1)(2)(4)(6)

12/31/2026  15%

9/22/2021

  500,000   500,000   14 
 

Preferred Stock *(1)(2)(4)

     

7/12/2013

  26,856,187   26,299,939   0 
 

Term Note (1)(2)(4)(6)

12/31/2026  8%

2/10/2017

  2,000,000   2,000,000   54 
 

Term Note (1)(2)(4)(6)

12/31/2026  8%

2/28/2014

  3,000,000   3,000,000   81 
                  754 
                    

LYNCEAN TECHNOLOGIES, INC.
(0.0%)
Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

     

7/3/2018

  869,792   1,000,000   0 
                    

REVASUM, INC.
(0.0%)
Semiconductor Equipment

CDIs *(2)(4)

     

11/14/2016 - 10/3/2022

  39,774,889   9,268,219   0 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

ACQUISITION
DATE

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

UCT COATINGS, INC.
((32.3%))
Advanced Materials

Common Stock *(1)(3)(4)

  

4/18/2011

1,500,000

 $

662,235

 $

 

143,560

 
             

WRIGHTSPEED, INC.

            

(0.0%)
Automotive

Common Stock *(1)(2)(4)

  

6/7/2019

69,102

  

7,460,850

  

0

 
 

Preferred Stock *(1)(2)(4)

6/7/2019-

7/20/2020

60,733,693

  

17,355,887

  

0

 
           

0

 
             

INVESTMENT COMPANY
((0.5%))

Fidelity Investments Money Market Treasury Portfolio - Class I 3.55% (5)(7)

  

Various

2,116

  

2,116

  

2,116

 
             

TOTAL INVESTMENTS
(Cost $89,860,375)
— (33.0%)

          

146,430

 

OTHER LIABILITIES IN EXCESS OF OTHER ASSETS — 133.0%

          

(590,487

)

NET ASSETS — 100.0%

         $

(444,057

)
             

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST RATE

 

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

 

COST BASIS

 

VALUE

 

INTRAOP MEDICAL CORP.

                

((0.6%))
Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/11/2019

  

500,000

 

$

500,000

 

$

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/22/2021

  

1,000,000

  

1,000,000

  

55

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/29/2019

  

500,000

  

500,000

  

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

10/6/2021

  

500,000

  

500,000

  

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

11/12/2021

  

500,000

  

500,000

  

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

11/29/2021

  

500,000

  

500,000

  

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

12/31/2018

  

10,961,129

  

10,961,129

  

600

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

2/27/2020

  

1,000,000

  

1,000,000

  

55

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

2/28/2022

  

200,000

  

200,000

  

11

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

3/25/2020

  

500,000

  

500,000

  

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

3/30/2022

  

150,000

  

150,000

  

8

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

3/8/2020

  

400,000

  

400,000

  

22

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

4/20/2021

  

1,000,000

  

1,000,000

  

55

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

4/6/2022

  

350,000

  

350,000

  

19

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

MATURITY DATE

 

INTEREST RATE

ACQUISITION
DATE

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

                    
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

6/10/2021

  

500,000

  

$

500,000

  

$

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

6/10/2022

  

700,000

   

700,000

   

38

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

7/12/2019

  

1,300,000

   

1,300,000

   

71

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

7/16/2021

  

500,000

   

500,000

   

27

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

7/31/2020

  

500,000

   

500,000

   

28

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

8/28/2020

  

750,000

   

750,000

   

41

 
 

Convertible Note (1)(2)(4)(6)

12/31/2026 

15

%

  

9/22/2021

  

500,000

   

500,000

   

27

 
 

Preferred Stock - Series C *(1)(2)(4)

      

7/12/2013

  

26,856,187

   

26,299,939

   

0

 
 

Term Note (1)(2)(4)(6)

12/31/2026 

8

%

  

2/10/2017

  

2,000,000

   

2,000,000

   

110

 
 

Term Note (1)(2)(4)(6)

12/31/2026 

8

%

  

2/28/2014

  

3,000,000

   

3,000,000

   

164

 
                   

1,523

 
                     

LYNCEAN TECHNOLOGIES, INC.
(0.0%)
Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

      

7/3/2018

  

869,792

   

1,000,000

   

0

 
                     

REVASUM, INC.
(0.0%)
Semiconductor Equipment

CDIs *(2)(4)

    11/14/2016-

10/3/2022

  

39,774,889

   

9,268,218

   

0

 

PORTFOLIO
COMPANY
(% OF NET
ASSETS)
AND INDUSTRY

TYPE OF
INVESTMENT

ACQUISITION
DATE

 

 

SHARES/PAR
VALUE ($)

  

COST BASIS

  

VALUE

 

UCT COATINGS, INC.
((71.3%))
Advanced Materials

Common Stock *(1)(3)(4)

  

4/18/2011

  

1,500,000

  

$

662,235

  

$

167,642

 
                 

WRIGHTSPEED, INC.

                

(0.0%)
Automotive

Common Stock *(1)(2)(4)

  

6/7/2019

  

69,102

   

7,460,851

   

0

 
 

Preferred Stock - Series AA *(1)(2)(4)

6/7/2019-

 7/20/2020

  

60,733,693

   

17,355,887

   

0

 
               

0

 
                 

INVESTMENT COMPANY
((23.9%))

Fidelity Investments Money Market Treasury Portfolio - Class I 3.66%(5)(7)

  

Various

  

56,271

   

56,271

   

56,271

 
                 

TOTAL INVESTMENTS
(Cost $89,914,530)
— (95.8%)

          

225,436

 

OTHER LIABILITIES IN EXCESS OF OTHER ASSETS — 195.8%

          

(460,564

)

NET ASSETS — 100.0%

         

$

(235,128

)